Navigation Links
Ion Torrent Ships New RNA Sequencing Application as Fast, Easy, Affordable Alternative to Microarrays
Date:5/31/2011

CARLSBAD, Calif., May 31, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it is now shipping the Ion Total RNA-Seq Kit for the Ion Personal Genome Machine (PGM™) sequencer, a solution that provides a fast, affordable, easy-to-use alternative to microarrays for transcript expression analysis. The Ion PGM sequencer puts RNA-Seq within the reach of any lab, enabling scientists to get far more accurate and comprehensive data than microarrays can provide for a comparable price.

RNA-Seq has always been the preferred method for studying gene expression because it provides the most complete information, such as transcript quantitation and the detection of novel transcripts and mutations. However, the cost and complexity of high-throughput next-generation sequencing technology has kept most researchers from adopting it. 

"It's been clear for years that there's a huge disconnect between the view of the transcriptome that we see from microarrays and the output of individual biological states that we get with sequencing," said Dr. Sean Grimmond, the Director of the Queensland Centre for Medical Genomics. "While RNA-Seq offers fantastic sensitivity and discrimination, cost and speed have been holding it back. Those are two areas where Ion Torrent technology excels, so this will be a very compelling application."

The Ion RNA-Seq is making RNA sequencing accessible to every scientist in world, with a fast, simple, solution that any lab can buy and use: 

  • The workflow is fast: Single-day workflow
    '/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
2. Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development
3. Kimberly-Clark Health Care Announces Strategic Green Partnerships, Commitment to Reducing Medical Waste
4. FHI Selected as Preferred Provider to a Consortium of Product Development Partnerships
5. Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
6. MedNet Solutions to Unveil iMedNet EDC at the 2011 Partnerships in Clinical Trials Conference
7. PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference
8. PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials
9. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
10. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
11. Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... May 16, 2013  Nektar Therapeutics, (Nasdaq: NKTR ... Robin , is scheduled to present at the upcoming ... at the Sheraton New York Hotel on Tuesday, ... The presentation will be accessible via a Webcast through a ... the Nektar website: http://www.nektar.com . This Webcast will be ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Ferret Study to be Part of Data Package ... 2007 /PRNewswire-FirstCall/ -- Novavax,Inc. said today that it ... challenge to ferrets inoculated with its pandemic,influenza vaccine, ... on,schedule later this year. , In the study, ...
... BOSTON--(BUSINESS WIRE)--May 2, 2007 - Acorda Therapeutics, ... Phase 3 clinical trial,of Fampridine-SR in people ... of Neurology meeting. Andrew Goodman, M.D.,Director of ... of,Rochester, presented top-line results on walking ability, ...
Cached Medicine Technology:Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 2Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7
(Date:5/18/2013)... (PRWEB) May 18, 2013 The product liability ... lawsuits on behalf of consumers nationwide who have sustained ... Shape-Ups toning shoes. These cases are all part of MDL ... Skechers lawsuits will be heard in the U.S. ... , Wright & Schulte, LLC specializes in defending the ...
(Date:5/17/2013)... Allen J. Schultz, D.D.S., is making the Laser ... available to residents of San Juan Capistrano. The laser ... than relying on a scalpel to cut the tissue away. ... on tightly defined wavelengths to target the diseased tissue and ... Only about one in every hundred dental professionals is trained ...
(Date:5/17/2013)... 2013 Stryker hip lawsuit claims ... and ABG II Modular-Neck Hip Stem recall continue to move ... According to court documents, a Case Management Conference was ... at which time the Court, among other things, set deadlines ... must submit Fact Sheets to Defendant and Liaison Counsel. ...
(Date:5/17/2013)... N.C., (PRWEB) May 17, 2013 Charlotte’s ... share the spotlight with children served by the Muscular ... event on Tuesday, May 21 at Bank of ... Team is a unique social event that pairs top ... fire fighters, with an “MDA Buddy” (a local child ...
(Date:5/17/2013)... 17, 2013 Parker Waichman LLP ... rights of victims injured by defective medical devices, notes ... said in a May 16, 2013, statement ... and ceramic-on-metal hip replacement products; specifically, the metal liners ... Acetabular Hip System will no longer be available worldwide ...
Breaking Medicine News(10 mins):Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:San Clemente, CA Periodontist, Dr. Allen J. Schultz, Now Provides Laser Gum Disease Treatment to Southern Orange County Periodontal Disease Patients 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 3Health News:MDA Hosts Annual Charlotte Muscle Team Event 2Health News:MDA Hosts Annual Charlotte Muscle Team Event 3Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3
... now widespread, CDC survey finds , MONDAY, April 26 ... have either high blood pressure, high cholesterol or diabetes, ... and other cardiovascular problems, a new government survey finds. ... and Nutrition Examination Survey (NHANES) 1999-2006 shows that 45 ...
... applauds President Obama,s selection of Donald Berwick, M.D., to ... and Medicaid Services. ASTRO looks forward to working closely ... critical healthcare reforms for patients and work toward system ... quality of care patients receive. ASTRO,s highest priority is ...
... Patients can decrease the frequency of Botox Cosmetic injections ... the same wrinkle-smoothing cosmetic benefits, according to new research ... two years of treatment at recommended intervals, patients can ... their Botox treatments by half," said Roger A. Dailey, ...
... type of immune cell are higher in head and neck cancer ... according to researchers at the University of Michigan Comprehensive Cancer Center. ... are most likely to respond to chemotherapy and radiation and allow ... the past, we would give toxic chemotherapy to a patient, look ...
... still time for media to register for the largest ... and publish early results from the International Polar Year ... Conference, WHEN: June 8 to 12, 2010, WHERE: Norway ... Oslo), MEDIA REGISTRATION: http://www.ipy-osc.no/article/2010/1265207747.88 The conference ...
... , ... Finn,s first book on both sides of the Atlantic. This layman,s account of his interest ... their own self worth, regardless of historical, cultural or religious backgrounds, as it strives to ... ...
Cached Medicine News:Health News:Nearly Half of U.S. Adults Have Heart Risk Factors 2Health News:Nearly Half of U.S. Adults Have Heart Risk Factors 3Health News:Botox reduces wrinkles even in less frequent doses 2Health News:Immune cells predict success of head and neck cancer treatment, U-M study finds 2Health News:World's largest polar science conference to take place in Oslo 2Health News:World's largest polar science conference to take place in Oslo 3Health News:Life Coach and Author Thomas Finn's Highly Anticipated Book, 'A Better Tomorrow- Affirmations and Visualizations the Keys to Success,' Debuts June 15 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: